Invitae announces debt transaction to refinance 2024 notes. Q4 results decent as ongoing restructuring continues. 2023 guidance could have been better. For the quarter, revenue came in at $122.45 ...

Genetic-testing company, Invitae (NYSE: NVTA), isn't as easy to understand as it might seem. After more than a year of pivoting and scaling down its operations, changing its leadership, and ...

It hasn't been the best quarter for Invitae Corporation (NYSE:NVTA) shareholders, since the share price has fallen 13% in that time. But in stark contrast, the returns over the last half decade have ...

Hello, everybody, and welcome to the Invitae Fourth Quarter 2020 Financial Results Conference Call. My name is Sam, and I will be coordinating your call today. [Operator Instructions] I would now like ...

Smart investors have a finger on the pulse of a company's financial health. And in Invitae's case, there are a few pressing problems. It isn't anywhere near the ballpark of becoming profitable anytime ...